On Tuesday, Resmed Inc (NYSE: RMD) opened at On Tuesday, N/A -0.00% from the last session, before settling in for the closing price of $247.66. Price fluctuations for RMD have ranged from $179.42 to $263.05 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 12.49% over the past five years. Company’s average yearly earnings per share was noted 22.96% at the time writing. With a float of $145.58 million, this company’s outstanding shares have now reached $146.87 million.
Let’s look at the performance matrix of the company that is accounted for 9980 employees. In terms of profitability, gross margin is 58.53%, operating margin of 32.1%, and the pretax margin is 31.41%.
Resmed Inc (RMD) Insider Updates
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Resmed Inc is 0.72%, while institutional ownership is 64.56%. The most recent insider transaction that took place on May 07 ’25, was worth 1,948,003. In this transaction Chief Executive Officer of this company sold 8,009 shares at a rate of $243.23, taking the stock ownership to the 455,503 shares. Before that another transaction happened on May 07 ’25, when Company’s Director sold 2,000 for $242.25, making the entire transaction worth $484,500. This insider now owns 71,218 shares in total.
Resmed Inc (RMD) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.45 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.96% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.65% during the next five years compared to 19.83% growth over the previous five years of trading.
Resmed Inc (NYSE: RMD) Trading Performance Indicators
Check out the current performance indicators for Resmed Inc (RMD). In the past quarter, the stock posted a quick ratio of 2.49. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.23. Likewise, its price to free cash flow for the trailing twelve months is 23.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 8.91, a number that is poised to hit 2.48 in the next quarter and is forecasted to reach 10.58 in one year’s time.
Technical Analysis of Resmed Inc (RMD)
Resmed Inc (NYSE: RMD) saw its 5-day average volume 1.04 million, a negative change from its year-to-date volume of 1.06 million. As of the previous 9 days, the stock’s Stochastic %D was 84.86%. Additionally, its Average True Range was 6.18.
During the past 100 days, Resmed Inc’s (RMD) raw stochastic average was set at 75.61%, which indicates a significant decrease from 89.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.00% in the past 14 days, which was higher than the 34.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $225.24, while its 200-day Moving Average is $234.52. Nevertheless, the first resistance level for the watch stands at $249.01 in the near term. At $250.38, the stock is likely to face the second major resistance level. The third major resistance level sits at $251.90. If the price goes on to break the first support level at $246.12, it is likely to go to the next support level at $244.60. Assuming the price breaks the second support level, the third support level stands at $243.23.
Resmed Inc (NYSE: RMD) Key Stats
There are currently 146,627K shares outstanding in the company with a market cap of 36.31 billion. Presently, the company’s annual sales total 4,685 M according to its annual income of 1,021 M. Last quarter, the company’s sales amounted to 1,292 M and its income totaled 365,040 K.
